AAAAAA

   
Results: 1-25 | 26-50
Results: 1-25/50

Authors: Kuschel, B Gayther, SA Easton, DF Ponder, BAJ Pharoah, PDP
Citation: B. Kuschel et al., Apparent human BRCAI knockout caused by mispriming during polymerase chainreaction: Implications for genetic testing, GENE CHROM, 31(1), 2001, pp. 96-98

Authors: Reynolds, L Jones, K Winton, DJ Cranston, A Houghton, C Howard, L Ponder, BAJ Smith, DP
Citation: L. Reynolds et al., C-cell and thyroid epithelial tumours and altered follicular development in transgenic mice expressing the long isoform of MEN 2A RET, ONCOGENE, 20(30), 2001, pp. 3986-3994

Authors: Ramus, SJ Fishman, A Pharoah, PDP Yarkoni, S Altaras, M Ponder, BAJ
Citation: Sj. Ramus et al., Ovarian cancer survival in Ashkenazi Jewish patients with BRCA1 and BRCA2 mutations, EUR J SUR O, 27(3), 2001, pp. 278-281

Authors: Antoniou, AC Pharoah, PDP McMullan, G Day, NE Ponder, BAJ Easton, D
Citation: Ac. Antoniou et al., Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study, GENET EPID, 21(1), 2001, pp. 1-18

Authors: Basham, VM Pharoah, PDP Healey, CS Luben, RN Day, NE Easton, DF Ponder, BAJ Dunning, AM
Citation: Vm. Basham et al., Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk, CARCINOGENE, 22(11), 2001, pp. 1797-1800

Authors: Ponder, BAJ
Citation: Baj. Ponder, Cancer genetics, NATURE, 411(6835), 2001, pp. 336-341

Authors: Daigo, Y Chin, SF Gorringe, KL Bobrow, LG Ponder, BAJ Pharoah, PDP Caldas, C
Citation: Y. Daigo et al., Degenerate oligonucleotide primed-polymerase chain reaction-based array comparative genomic hybridization for extensive amplicon profiling of breast cancers - A new approach for the molecular analysis of paraffin-embedded cancer tissue, AM J PATH, 158(5), 2001, pp. 1623-1631

Authors: Werness, BA Parvatiyar, P Ramus, SJ Whittemore, AS Garlinghouse-Jones, K Oakley-Girvan, I DiCioccio, RA Wiest, J Tsukada, Y Ponder, BAJ Piver, MS
Citation: Ba. Werness et al., Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53, J NAT CANC, 92(13), 2000, pp. 1088-1091

Authors: Lakhani, SR Gusterson, BA Jacquemier, J Sloane, JP Anderson, TJ van de Vijver, MJ Venter, D Freeman, A Antoniou, A McGuffog, L Smyth, E Steel, CM Haites, N Scott, RJ Goldgar, D Neuhausen, S Daly, PA Ormiston, W McManus, R Scherneck, S Ponder, BAJ Futreal, PA Peto, J Stoppa-Lyonnet, D Bignon, YJ Struewing, JP Bishop, DT Klijn, JGM Devilee, P Cornelisse, CJ Lasset, C Lenoir, G Barkardottir, RB Egilsson, V Hamann, U Chang-Claude, J Sobol, H Weber, B Easton, DF Stratton, MR
Citation: Sr. Lakhani et al., The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2, CLIN CANC R, 6(3), 2000, pp. 782-789

Authors: Healey, CS Dunning, AM Teare, MD Chase, D Parker, L Burn, J Chang-Claude, J Mannermaa, A Kataja, V Huntsman, DG Pharoah, PDP Luben, RN Easton, DF Ponder, BAJ
Citation: Cs. Healey et al., A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability, NAT GENET, 26(3), 2000, pp. 362-364

Authors: Gayther, SA Batley, SJ Linger, L Bannister, A Thorpe, K Chin, SF Daigo, Y Russell, P Wilson, A Sowter, HM Delhanty, JDA Ponder, BAJ Kouzarides, T Caldas, C
Citation: Sa. Gayther et al., Mutations truncating the EP300 acetylase in human cancers, NAT GENET, 24(3), 2000, pp. 300-303

Authors: Harland, M Holland, EA Ghiorzo, P Mantelli, M Bianchi-Scarra, G Goldstein, AM Tucker, MA Ponder, BAJ Mann, GJ Bishop, DT Bishop, JN
Citation: M. Harland et al., Mutation screening of the CDKN2A promoter in melanoma families, GENE CHROM, 28(1), 2000, pp. 45-57

Authors: Brown, J Coulthard, A Dixon, AK Dixon, JM Easton, DF Eeles, RA Evans, DGR Gilbert, FG Hayes, C Jenkins, JPR Leach, MO Moss, SM Padhani, AP Pointon, LJ Ponder, BAJ Sloane, JP Turnbull, LW Walker, LG Warren, RML Watson, W
Citation: J. Brown et al., Rationale for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer, BREAST, 9(2), 2000, pp. 72-77

Authors: Brown, J Coulthard, A Dixon, AK Dixon, JM Easton, DF Eeles, RA Evans, DGR Gilbert, FG Hayes, C Jenkins, JPR Leach, MO Moss, SM Padhani, AP Pointon, LJ Ponder, BAJ Sloane, JP Turnbull, LW Walker, LG Warren, RML Watson, W
Citation: J. Brown et al., Protocol for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer, BREAST, 9(2), 2000, pp. 78-82

Authors: Pharoah, PDP Lipscombe, JM Redman, KL Day, NE Easton, DF Ponder, BAJ
Citation: Pdp. Pharoah et al., Familial predisposition to breast cancer in a British population: implications for prevention, EUR J CANC, 36(6), 2000, pp. 773-779

Authors: Antoniou, AC Gayther, SA Stratton, JF Ponder, BAJ Easton, DF
Citation: Ac. Antoniou et al., Risk models for familial ovarian and breast cancer, GENET EPID, 18(2), 2000, pp. 173-190

Authors: Brown, J Buckley, D Coulthard, A Dixon, AK Dixon, JM Easton, DF Eeles, RA Evans, DGR Gilbert, FG Graves, M Hayes, C Jenkins, JPR Jones, AP Keevil, SF Leach, MO Liney, GP Moss, SM Padhani, AR Parker, GJM Pointon, LJ Ponder, BAJ Redpath, TW Sloane, JP Turnbull, LW Walker, LG Warren, RML
Citation: J. Brown et al., Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study, MAGN RES IM, 18(7), 2000, pp. 765-776

Authors: Werness, BA Ramus, SJ Whittemore, AS Garlinghouse-Jones, K Oakley-Girvan, I DiCioccio, RA Tsukada, Y Ponder, BAJ Piver, MS
Citation: Ba. Werness et al., Primary ovarian dysgerminoma in a patient with a germline BRCA1 mutation, INT J GYN P, 19(4), 2000, pp. 390-394

Authors: Healey, CS Dunning, AM Durocher, F Teare, D Pharoah, PDP Luben, RN Easton, DF Ponder, BAJ
Citation: Cs. Healey et al., Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk, CARCINOGENE, 21(2), 2000, pp. 189-193

Authors: Piver, MS Tsukada, Y Werness, BA DiCioccio, RA Whittemore, AS Ponder, BAJ
Citation: Ms. Piver et al., Comparative study of ovarian cancer histopathology by registry pathologists and referral pathologists: A study by the Gilda Radner Familial Ovarian Cancer Registry, GYNECOL ONC, 78(2), 2000, pp. 166-170

Authors: Werness, BA Ramus, SJ Whittemore, AS Garlinghouse-Jones, K Oakley-Girvan, I DiCioccio, RA Tsukada, Y Ponder, BAJ Piver, MS
Citation: Ba. Werness et al., Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations, HUMAN PATH, 31(11), 2000, pp. 1420-1424

Authors: Huen, DS Elsdon, M Ponder, BAJ
Citation: Ds. Huen et al., The Drosophila Ret gene is transcribed in multiple alternatively spliced forms, MOL G GENET, 264(3), 2000, pp. 335-340

Authors: Seltmann, M Harrington, P Ponder, BAJ Willatt, LR Heppell-Parton, AC Anton-Culver, H
Citation: M. Seltmann et al., A case of inv dup(8p) with early onset breast cancer, J MED GENET, 37(1), 2000, pp. 70-71

Authors: Russell, PA Pharoah, PDP De Foy, K Ramus, SJ Symmonds, I Wilson, A Scott, I Ponder, BAJ Gayther, SA
Citation: Pa. Russell et al., Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers, INT J CANC, 87(3), 2000, pp. 317-321

Authors: Sutcliffe, S Pharoah, PDP Easton, DF Ponder, BAJ
Citation: S. Sutcliffe et al., Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer, INT J CANC, 87(1), 2000, pp. 110-117
Risultati: 1-25 | 26-50